Reich, K., K. Papp, A. Blauvelt, R. Langley, A. Armstrong, R. Warren, K. Gordon, J. Merola, C. Madden, M. Wang, V. Vanvoorden, and M. Lebwohl. “Efficacy and Safety of Bimekizumab in Patients With Moderate to Severe Plaque Psoriasis: Results from BE VIVID, a 52-Week Phase 3, Randomized, Double-Blinded, Ustekinumab- and Placebo-Controlled Study”. SKIN The Journal of Cutaneous Medicine, vol. 4, no. 6, Oct. 2020, p. s82, doi:10.25251/skin.4.supp.82.